文献速递关节外科骨质疏松与代谢性骨病

接受全关节置换术患者肌少症的患病率与临床影响:系统评价与Meta分析

Prevalence and Clinical Impact of Sarcopenia in Patients Undergoing Total Joint Arthroplasty: A Systematic Review and a Meta-Analysis.
PubMed 文献 · J Arthroplasty · 2024-06-18

该系统评价与Meta分析纳入13项研究、399097例患者,评估全关节置换术(TJA)患者肌少症患病率及其对医疗与手术结局的影响。全膝关节置换术(TKA)肌少症合并患病率为20.1%(95%CI 13.6至28.8%;P<0.00001;I²=94.7%),全髋关节置换术(THA)为5.2%(95%CI 0.1至69.7%;P=0.128;I²=99.6%)。肌少症与TKA后输血、肺炎、尿路感染、假体周围骨折、假体脱位及机械性松动风险升高相关,并与THA后尿路感染和假体松动风险升高相关。

要点

  • TKA患者肌少症合并患病率为20.1%,THA为5.2%。
  • 肌少症增加TKA后输血、肺炎、尿路感染、假体周围骨折、脱位及机械性松动风险。
  • 肌少症增加THA后尿路感染和假体松动风险。

核心结论

  • 基线肌少症在TJA患者中常见,且与TKA和THA后尿路感染及假体松动风险升高相关,并与TKA后输血、肺炎、假体周围骨折和机械性松动风险升高相关。

研究设计与样本

  • 系统评价与Meta分析,检索PubMed、Scopus、Cochrane和Google Scholar数据库,纳入13项研究、共399097例患者,采用随机效应模型合并数据。

主要发现

  • TKA患者肌少症合并患病率为20.1%(95%CI 13.6至28.8%;P<0.00001;I²=94.7%),THA患者为5.2%(95%CI 0.1至69.7%;P=0.128;I²=99.6%)。
  • Meta回归未发现年龄、性别、体重指数、糖尿病、肥胖、关节置换类型与TJA患者肌少症患病率之间存在关联。
  • 在TKA中,肌少症增加输血风险(OR 4.68,95%CI 3.51至6.25;P<0.00001)、肺炎风险(OR 1.94,95%CI 1.14至3.30;P=0.01)、尿路感染风险(OR 1.64,95%CI 1.31至2.05;P<0.001)、假体周围骨折风险(OR 2.12,95%CI 1.51至2.98;P<0.0001)、假体脱位风险(OR 1.99,95%CI 1.62至2.44;P<0.00001)和机械性松动风险(OR 1.78,95%CI 1.43至2.22;P<0.00001)。
  • 在THA中,肌少症患者尿路感染风险升高(OR 1.79,95%CI 1.32至2.43;P=0.0002),假体松动风险升高(OR 1.97,95%CI 1.10至3.53;P=0.02)。

局限性

  • TKA肌少症患病率合并分析异质性I²=94.7%,THA为I²=99.6%。
  • THA肌少症患病率合并分析置信区间宽(95%CI 0.1至69.7%),且未达统计学显著(P=0.128)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Sarcopenia is a progressive loss of skeletal muscle mass and function. It is associated with adverse outcomes after several orthopaedic procedures. However, its role in total joint arthroplasty (TJA) is not fully explored. Therefore, we wanted to conduct a systematic review and meta-analysis to answer the following questions: (1) What is the prevalence of sarcopenia in patients undergoing TJA?; (2) What factors are associated with the prevalence of sarcopenia in patients undergoing TJA?; What is the impact of sarcopenia on medical outcomes following TJA?; and (4) What is the impact of sarcopenia on surgical outcomes following TJA? METHODS: Electronic databases PubMed, Scopus, Cochrane, and Google Scholar were searched. The data were pooled using the random-effects model and graphically represented by a forest plot. We included a total of 13 studies, evaluating 399,097 patients. RESULTS: The pooled prevalence of sarcopenia was 20.1% (95% confidence interval [CI] 13.6 to 28.8%; P < .00001; I2 = 94.7%) in total knee arthroplasty (TKA) and 5.2% (95% CI 0.1 to 69.7%; P = .128; I2 = 99.6%) in total hip arthroplasty (THA). Meta-regression found no links between age, sex, body mass index, diabetes, obesity, arthroplasty type, and sarcopenia prevalence in TJA. Sarcopenia increased risk of blood transfusion (odds ratio [OR] 4.68 [95% CI 3.51 to 6.25]; P < .00001), pneumonia (OR 1.94 [95% CI 1.14 to 3.30]; P = .01), urinary tract infection (UTI) (OR 1.64 [95% CI 1.31 to 2.05]; P < .001), prosthetic fracture (OR 2.12 [95% CI 1.51 to 2.98]; P < .0001), prosthetic dislocation (OR 1.99 [95% CI 1.62 to 2.44]; P < .00001), and mechanical loosening (OR 1.78 [95% CI 1.43 to 2.22]; P < .00001) in TKA. Sarcopenic patients were at an increased risk of UTI (OR 1.79 [95% CI 1.32 to 2.43]; P = .0002) and prosthetic loosening (OR 1.97 [95% CI 1.10 to 3.53]; P = .02) post-THA. CONCLUSIONS: Baseline sarcopenia was prevalent in patients undergoing TJA. It was associated with an increased risk of UTI and prosthetic loosening following TKA and THA. Increased risk of blood transfusion, pneumonia, prosthetic fractures, and mechanical loosening following TKA.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Sumbal R, Abbas M, Sheikh SM, et al. Prevalence and Clinical Impact of Sarcopenia in Patients Undergoing Total Joint Arthroplasty: A Systematic Review and a Meta-Analysis. J Arthroplasty. 2024. PMID: 38901711. doi:10.1016/j.arth.2024.06.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。